Premium
Emerging role of bevacizumab in management of patients with symptomatic hepatic involvement in Hereditary Hemorrhagic Telangiectasia
Author(s) -
Chavan Ajay,
SchumannBinarsch Silke,
Schmuck Bernhard,
Oltmer Franziska,
Geisthoff Urban,
Hoppe Florian,
Wirsching Kornelia,
Klempnauer Juergen,
Manns Michael,
Philip Thomas Rohit,
Köhne ClausHenning
Publication year - 2017
Publication title -
american journal of hematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.456
H-Index - 105
eISSN - 1096-8652
pISSN - 0361-8609
DOI - 10.1002/ajh.24878
Subject(s) - medicine , bevacizumab , liver transplantation , asymptomatic , surgery , tolerability , clinical endpoint , transplantation , telangiectasia , gastroenterology , chemotherapy , clinical trial , adverse effect